Latest Emerging Markets News

BlackRock Investment Management (Australia) Limited has announced final cash distributions for 16 Australian-listed iShares ETFs, with payments scheduled for early January 2026. The announcement outlines distribution amounts, key dates, and important investor compliance reminders.

Simble Solutions has acquired exclusive rights to a cutting-edge 3D zinc oxide nanosensor technology and completed a $2.5 million placement, positioning itself to expand its IoT platform into new safety and environmental monitoring markets.

Advanced Innergy Holdings Ltd (AIH) has delivered strong audited FY25 financial results, marked by solid revenue growth, improved profitability, and strategic acquisitions, while confirming FY26 guidance and debuting on the ASX.

FAR Limited has agreed to promptly pay Woodside Energy a $6 million claim related to the 2021 sale of its interest in the RSSD Project, with a potential refund if Woodside recovers disputed costs from Senegal authorities.

PlaySide Studios is gearing up for a pivotal 2026 with its highly anticipated game launch and strategic expansion into the MENAT region, underpinned by strong cost savings and leadership hires.

SportsHero Limited has secured its largest-ever cash receipt of approximately A$530,000 following the successful rollout of its iGV.Com Game Pass in the Philippines, marking a pivotal step in its commercial journey.

Gold Hydrogen Limited’s latest drilling at Ramsay 4 confirms significant natural hydrogen and helium formations, setting the stage for critical flow testing in early 2026 to assess commercial viability.

Sovereign Metals has entered a strategic collaboration with the International Finance Corporation to advance sustainable development and financing of its Kasiya Rutile-Graphite Project in Malawi.

Pacific Lime and Cement Limited has secured a strategic advisory partnership with the International Finance Corporation to advance Papua New Guinea’s inaugural vertically integrated clinker and cement production project.

Immutep Limited reports robust progress in its pivotal Phase III TACTI-004 trial for advanced non-small cell lung cancer, with over 120 clinical sites activated across 27 countries including the US. Patient enrolment has reached 38% of the target, keeping key milestones on track.

Arcadia Minerals announces key leadership departures and a strategic pivot towards gold and critical minerals acquisitions, alongside planned drilling at its promising TVC Project in Namibia.

Immutep has struck a strategic licensing deal with Dr. Reddy’s, granting rights to commercialise its novel cancer immunotherapy Eftilagimod Alfa across key emerging markets. The agreement includes a $20 million upfront payment and potential milestones exceeding $349 million.